Welcome to our dedicated page for JANUS LIVING news (Ticker: JAN), a resource for investors and traders seeking the latest updates and insights on JANUS LIVING stock.
Janus Living, Inc. reports developments as a pure-play senior housing real estate investment trust focused on senior housing communities across the United States. Company news centers on quarterly operating results, same-store revenue, occupancy and RevPOR trends, dividend declarations, liquidity actions, acquisition and investment activity, and the use of proceeds from its completed initial public offering.
Recurring updates also address Janus Living’s Class A-1 common stock trading on the New York Stock Exchange, its external management relationship with Healthpeak Properties, and capital resources such as unsecured revolving credit and term loan facilities used for general corporate purposes and portfolio growth.
Janus Living (NYSE: JAN), a senior housing REIT, launched a public offering of 25,000,000 Class A-1 common shares under an SEC Form S-11 registration.
The company may grant underwriters a 30-day option for 3,750,000 additional shares and plans to use net proceeds for acquisitions, investments and general corporate purposes.
Janus Living (NYSE: JAN) declared common stock cash dividends for Q1 and Q2 2026. The Board set a pro rata Q1 dividend of $0.0174 per common share and a Q2 dividend of $0.1425 per common share, with an annualized dividend of $0.57 per share.
Both dividends share a record date of Friday, June 12, 2026 and a payment date of Wednesday, June 24, 2026.
Janus Living (NYSE: JAN)/b) reported first quarter 2026 results for the period ended March 31, 2026. Consolidated revenues were
Healthpeak Properties (NYSE: DOC) reported Q1 2026 results and updated 2026 guidance after Janus Living's IPO and strategic transactions. Key points: net income $0.28 per share, FFO as Adjusted $0.45 per share, Janus IPO net proceeds of $880 million, and Healthpeak repurchased 5.9M shares for ~$100M.
The company completed senior housing contributions to Janus, closed an outpatient portfolio recapitalization, generated $267M of proceeds, and reported Net Debt to Adjusted EBITDAre of 5.4x.
Janus Living (NYSE: JAN) will report first quarter 2026 financial results after market close on Tuesday, May 5, 2026. The company will hold a conference call and webcast on Wednesday, May 6, 2026 at 12:00 p.m. ET to review results and operating performance.
Webcast access and dial-in details are provided, and a replay will remain available on the company website through May 5, 2027.
Janus Living (NYSE: JAN) closed a new unsecured Credit Facility totaling $600 million, comprising a $500 million unsecured revolving facility (maturing March 2030 with two six-month extensions) and a $100 million unsecured delayed-draw term loan (maturing March 2031).
Borrowings carry interest at SOFR plus 105–110 bps based on leverage pricing. The Credit Facility was undrawn at closing and increases total liquidity to approximately $1.5 billion as of March 23, 2026. The company expects to use liquidity for future growth and general corporate purposes.
Healthpeak Properties (NYSE: DOC) and Janus Living (NYSE: JAN) announced that Janus Living completed an initial public offering of 48,300,000 Class A-1 shares at $20.00 per share, including full exercise of a 6,300,000-share underwriter option. Shares began trading on March 20, 2026 under JAN.
Net proceeds were approximately $878 million, to be used for acquisitions, investments meeting Janus Living’s criteria and general corporate purposes. Lead book-runners were BofA Securities and J.P. Morgan.
Janus Living (NYSE: JAN) makes its public debut on March 20, 2026, beginning trading on the New York Stock Exchange with an on-site IPO celebration.
The NYSE pre-market update also notes market moves, a Guardian Metal Resources listing on NYSE American, and upcoming small‑cap conference activity.
Healthpeak Properties (NYSE:DOC) and Janus Living priced Janus Living’s upsized IPO of 42,000,000 Class A-1 shares at $20.00 per share, with a 30-day underwriter option for an additional 6,300,000 shares. Janus Living expects NYSE trading to begin on March 20, 2026 under ticker JAN, and closing is expected on March 23, 2026, subject to customary conditions.
After the IPO, Healthpeak will own approximately 214,734,000 Janus Living shares, representing an approximate 83.6% voting interest (81.6% if the option is fully exercised). Proceeds will be used for acquisitions, investments, and general corporate purposes.
JanOne Inc. (Nasdaq: JAN) announced a corporate rebranding to ALT5 Sigma , effective July 15, 2024. This includes a change in its Nasdaq ticker symbol from JAN to ALTS and a new website address, alt5sigma.com. These changes are part of a strategic shift to focus on fintech, particularly the ALT5 Sigma fintech platform, while maintaining its biotech initiatives. The company processed over $1.2 billion in cryptocurrency transactions in 2023 through its fintech platforms, ALT5 Pay and ALT5 Prime. Stockholders are not required to take any action with respect to these changes.